HSP 57.67 Hospira Inc $HSP Hit a 52 week high of 58.18

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
HSP 57.67 Hospira Inc $HSP Hit a 52 week high of 58.18 Closing the day 09:44 at 57.67 -0.42 -0.72% With a day low of 57.65 and a total volume of 14,452.

HSP Recent Posts: http://investorshangout.com/Hospira-Inc-HSP-51354/

HSP Hospira Inc Recent Headline News

Hospira Has Returned 11.8% Since SmarTrend Recommendation (HSP)
Comtex SmarTrend(R) - 1 hr 33 mins ago
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 3 weeks, Hospira has returned 11.79% as of today's recent price of $57.95.
HSP: 58.21 (+0.12)

Earnings Triple Plays
Bespoke Investment Group - Seeking Alpha - Wed Nov 12, 1:54AM CST
The third quarter earnings season unofficially comes to an end on Thursday when Wal-Mart (NYSE: WMT ) reports earnings before the open. So far this earnings season, more than 2,000 companies have reported their quarterly numbers, and our job here is...
GD: 142.74 (+0.03), ACT: 244.79 (+3.16), CBG: 32.42 (-0.27), HCP: 43.41 (-0.51), BCR: 164.44 (-1.15), PCG: 49.72 (-0.05), AMGN: 157.72 (-3.13), CB: 101.62 (+0.15), SRE: 109.24 (-0.27), PLD: 40.90 (-0.20), HSP: 58.21 (+0.12), TWX: 79.85 (+0.87), KIM: 24.54 (-0.20), CMI: 144.84 (+0.32), ALXN: 188.47 (-5.12), ESS: 199.46 (-1.06), ABBV: 63.48 (-0.15), CAT: 101.02 (-0.09), AAPL: 113.99 (+1.17)

Amgen's brodalumab beats Stelara in Phase 3 trial
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 3:52PM CST

CANF: 2.52 (+0.01), JNJ: 108.38 (-0.69), IDRA: 2.44 (-0.01), DERM: 16.01 (-0.23), MRK: 58.80 (-0.74), PFE: 30.26 (-0.16), AZN: 72.73 (-1.80), AMGN: 157.72 (-3.13), GSK: 45.67 (+0.01), HSP: 58.21 (+0.12), NVS: 93.98 (-0.40), CELG: 103.03 (-4.40)

Hospira Inc.'s Third-Quarter Earnings: The 3 Key Takeaways
Leo Sun, The Motley Fool - Motley Fool - Fri Nov 07, 10:53AM CST
Shares of Hospira jumped nearly 7% on Nov. 6 after the maker of injectable drugs and infusion technologies reported impressive third-quarter earnings. Source: Wikimedia Commons. Hospira's revenue climbed 2% year over year to $1.2 billion,...
HSP: 58.21 (+0.12)

Stock Market News for November 07, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:10AM CST
Benchmarks ended in the green zone yesterday following ECB President Mario Draghi’s statement regarding possible expansion of monetary stimulus by the European Central Bank
DHI: 24.45 (+0.16), WFM: 46.56 (-0.16), TSLA: 254.29 (+2.59), LEN: 45.74 (+0.08), QCOM: 70.80 (+0.15), PHM: 20.87 (+0.06), TOL: 33.44 (-0.29), GNW: 9.22 (-0.08), HSP: 58.21 (+0.12)

Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:25AM CST
Hospira (HSP) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 85.94 (+0.99), ABAX: 55.05 (+0.04), GWPH: 75.58 (-0.26), HSP: 58.21 (+0.12)

Look for Shares of Hospira to Potentially Pullback after Yesterday's 6.67% Rise
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 58.21 (+0.12)

Watch for Hospira to Potentially Pullback After Gaining 6.67% Yesterday
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 58.21 (+0.12)

Hospira Beats on Earnings & Sales in Q3, Narrows Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:53PM CST
Hospira reported third-quarter 2014 adjusted earnings of 74 cents per share.
AGN: 197.48 (+1.27), ABAX: 55.05 (+0.04), ABBV: 63.48 (-0.15), HSP: 58.21 (+0.12)

Hospira (HSP) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Thu Nov 06, 12:39PM CST
The following Hospira (HSP) conference call took place on November 6, 2014, 09:00 AM ET. This is a transcript of that earnings call:
HSP: 58.21 (+0.12)

Hospira's (HSP) CEO Michael Ball on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 12:20PM CST

HSP: 58.21 (+0.12)

Hospira Q3 income up big
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:11AM CST

HSP: 58.21 (+0.12)

Hospira (HSP) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 7:55AM CST

HSP: 58.21 (+0.12)

Hospira unveils generic Paricalcitol Injection in three multi-dose sizes
M2 - Thu Nov 06, 7:28AM CST
Injectable drug company
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ridero Innovates with $2.7M to Tackle Auto Finance Woes

Updated Category News Views 93

Ridero Gets Serious About Fixing Auto Financing When you've got startups like Ridero stepping up with a $2.7 million cash infusion, you can't help but sit up and listen. These folks are charging head-on into the automotive financing jumble, and they're bringing some high-tech toys to the party. With RiverPark Ventures and a slew of other big-name backers, Ridero's dialing...

Continue Reading
Gildan Faces Class Action Over Alleged Market Missteps

Updated Category News Views 64

Legal Storm Brews Over Gildan's Securities Conduct Listen, investors are no strangers to turbulence. But when a company's integrity takes a nosedive, that's when things get precarious fast. Gildan Activewear Inc. (NYSE: GIL) finds itself neck-deep in legal trouble, thanks to alleged securities law violations. On November 9, 2026, DJS Law Group got the ball rolling on a...

Continue Reading
Western Digital Faces Investigation Over Fiduciary Breaches

Updated Category News Views 42

Ringside Seat to Western Digital's Legal Turbulence If there's one thing that'll make an investor's hair stand on end, it's the whisper of fiduciary breaches. Western Digital Corporation (NASDAQ:WDC) just took a hit from Levi & Korsinsky, LLP, who've launched a full-scale investigation into potential breaches of fiduciary duties by select officers and directors. When a...

Continue Reading
Ericsson Buybacks: Strategic Moves or Market Maneuver?

Updated Category News Views 106

Breaking Down Ericsson's Strategic Share Buybacks When a company like Ericsson starts pulling stocks off the shelves like they're on sale, it's time to take notice. Between November 2nd and 6th, Ericsson, that telecom giant we all know, went on a little shopping spree, snapping up 500,000 of its own Class B shares. Why should we care? Well, it's a part of their hefty SEK...

Continue Reading
Energenesis Tackles Space Anemia with ATP Boost

Updated Category News Views 59

Gearing Up for Space Medicine: Enter Energenesis With the cosmic frontier drawing investor eyes and day-to-day operations inching skyward, here comes Energenesis Biomedical (TWSE: 6657), poking its head into space medicine. This isn’t just another biotech firm looking to throw drugs at terrestrial problems. No, Energenesis shot its shot at TASTI 2026 with its...

Continue Reading
CD Rates on the Rise: What Savers Need to Know

Updated Category News Views 23

CD Rates: A Change in the Winds If you think of certificates of deposit (CDs) like a quiet corner booth at your local bar, you might be in for a surprise. Right now, it feels like the DJ just turned up the volume. We've seen a noteworthy 88% of rate changes heading upward lately, according to CD Valet's latest data. In numbers that speak loud and clear, the median CD rate...

Continue Reading
NSAP's First Board Aims to Revolutionize Autism Care

Updated Category News Views 11

Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...

Continue Reading
Paul Taubman Takes Helm at Cold Spring Harbor Lab

Updated Category News Views 217

Paul Taubman Steers the Ship at CSHL Here's the buzz coming out of Cold Spring Harbor Lab: they're handing the reins over to Paul Taubman. It's like swapping captains in the middle of the ocean—big shoes need to stay afloat. This place isn't just the playground for science nerds; it's a powerhouse in biomedical research. Now, we've got Taubman, a fella who's been...

Continue Reading
Quest Diagnostics at Jefferies Conference: What’s Next?

Updated Category News Views 54

Quest Diagnostics Set for the Spotlight in London You're sipping your morning coffee when you hear that Quest Diagnostics (NYSE: DGX) is gearing up for a fireside chat in the UK's capital. Now, this isn't a random chit-chat we're talking about. Sam Samad, the man handling the books as their CFO, will be chatting it up at the Jefferies Global Healthcare Conference on...

Continue Reading
Creality's Kid-Friendly AI 3D Printer Debuts at $329

Updated Category News Views 7

Creality Unpacks mBox for Young Innovators You squint at the market to find the next big thing, and here comes Creality tossing a fancy innovation into the ring. Meet the mBox—a kid-operated, AI-driven 3D printer. This little contraption is set to spark youthful imagination, not just buzz amongst hobbyist circles. They're rolling this out on TikTok Shop from November 9...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover the Latest Updates from Pardee Resources Company

Updated Category News Views 166

Pardee Resources Company Releases Second Quarter Report Pardee Resources Company (OTC: PDER) has shared its second quarter report, now accessible on the OTC Markets website. This release provides insightful information regarding the company's performance during the second quarter, highlighting key achievements and challenges. Understanding the Recent Report The second...

Continue Reading
Leadership Transformation at South Street Securities Holdings

Updated Category News Views 168

Transformative Leadership at South Street Securities Holdings South Street Securities Holdings, Inc. is excited to announce the appointment of Andrea Pfenning to its Board of Directors. With an impressive background forged over three decades in banking, Andrea's addition comes at a pivotal time as South Street aims to bolster its core offerings and explore new growth...

Continue Reading
Figma Buzz Integrates With Bynder for Enhanced Design Workflow

Updated Category News Views 251

Revolutionizing Design Workflows with Figma Buzz and Bynder In an exciting development for the creative industry, Figma Buzz has integrated directly with Bynder and a variety of other digital asset management (DAM) systems through the LinkrUI connector. This new feature greatly enhances the way designers and creative teams can access assets, streamlining the content...

Continue Reading
NextEra Energy Overview: Key Growth Factors and Investor Insights

Updated Category News Views 148

Understanding NextEra Energy's Position in the Market NextEra Energy (NYSE: NEE) has shown resilience and growth in a challenging environment for utilities stocks, with an approximate 24% increase in value over the past year. Most of this gain has manifested recently as the company reported stronger performance metrics, particularly in the early part of the year. As NEE...

Continue Reading
Field Medical Secures $35 Million to Enhance VT Treatment Innovation

Updated Category News Views 234

Introduction to Field Medical's Funding Success Field Medical, Inc. has recently announced the successful closure of a $35 million Series B financing round aimed at enhancing its innovative FieldForce™ Pulled Field Ablation Platform. This important milestone marks the company's commitment to advancing cardiac ablation technologies and positions it at the forefront of...

Continue Reading